KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

NXP Semiconductors (NXPI) Research & Development (2016 - 2026)

NXP Semiconductors' Research & Development history spans 18 years, with the latest figure at $588.0 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 7.5% to $588.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.4 billion, a 3.05% increase, with the full-year FY2025 number at $2.4 billion, up 0.55% from a year prior.
  • Research & Development hit $588.0 million in Q1 2026 for NXP Semiconductors, down from $665.0 million in the prior quarter.
  • Over the last five years, Research & Development for NXPI hit a ceiling of $665.0 million in Q4 2025 and a floor of $518.0 million in Q2 2022.
  • Historically, Research & Development has averaged $580.1 million across 5 years, with a median of $577.0 million in 2023.
  • Biggest five-year swings in Research & Development: rose 20.56% in 2023 and later decreased 5.99% in 2024.
  • Tracing NXPI's Research & Development over 5 years: stood at $540.0 million in 2022, then grew by 20.56% to $651.0 million in 2023, then dropped by 5.99% to $612.0 million in 2024, then grew by 8.66% to $665.0 million in 2025, then fell by 11.58% to $588.0 million in 2026.
  • Business Quant data shows Research & Development for NXPI at $588.0 million in Q1 2026, $665.0 million in Q4 2025, and $575.0 million in Q3 2025.